Investigators conducted a systemic review to summarize evidence regarding the use systemic Janus kinase inhibitors in patients with refractory nonsegmental vitiligo.

Research into vitiligo could lead to new treatment options within the next few years, a dermatologist involved in the study ...

Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying ...

Vitiligo patches appear first on sun-exposed parts of the ... The light-colored or white spots on the face of children ...

Two studies were done to see if Opzelura was safe and effective for the treatment of vitiligo, compared with a placebo. Placebo-controlled studies help researchers see differences in benefit or ...

A few days ago, millions around the world cheered when the US Food and Drug Administration (FDA) approved a treatment for vitiligo - a topical cream that can restore pigment with unprecedented ...

"Notably, the study found that the thresholds for meaningful change are lower than those typically established in clinical ...

This work has provided valuable insight into how patients with vitiligo evaluate treatment success and has laid the foundation for creating a validated patient-rated outcome measure for use in ...

This article outlines the association between vitiligo and hearing loss, including treatment options, typical outlook, and when to contact a doctor. The inner ear contains cells called melanocytes ...

A review highlighting the need to improve vitiligo care through understanding the role of the JAK-STAT pathway, early diagnosis ...

Research indicates elevated cardiovascular risk in vitiligo patients, underscoring the necessity for enhanced monitoring and ...

Research into vitiligo could lead to new treatment options within the next few years, a dermatologist involved in the study has said. Viktoria Eleftheriadou has studied the disease since 2009 ...